3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide

C100H74BrF5N20O16 — CID 157132771

IUPAC3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide
SMILESCOc1cccc(CC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)cc2)c1.O=C(Cc1cc(F)cc(F)c1)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)cc1.O=C(Cc1ccccc1)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)cc1.O=C(Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)cc1)c1cccc(Br)c1.O=C(Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)cc1)c1cccc(C(F)(F)F)c1
InChIInChI=1S/C21H18N4O4.C20H13F3N4O3.C20H14F2N4O3.C20H16N4O3.C19H13BrN4O3/c1-28-16-4-2-3-13(11-16)12-18(26)23-14-5-7-15(8-6-14)29-17-9-10-22-20-19(17)24-21(27)25-20;21-20(22,23)12-3-1-2-11(10-12)18(28)25-13-4-6-14(7-5-13)30-15-8-9-24-17-16(15)26-19(29)27-17;21-12-7-11(8-13(22)10-12)9-17(27)24-14-1-3-15(4-2-14)29-16-5-6-23-19-18(16)25-20(28)26-19;25-17(12-13-4-2-1-3-5-13)22-14-6-8-15(9-7-14)27-16-10-11-21-19-18(16)23-20(26)24-19;20-12-3-1-2-11(10-12)18(25)22-13-4-6-14(7-5-13)27-15-8-9-21-17-16(15)23-19(26)24-17/h2-11H,12H2,1H3,(H,23,26)(H2,22,24,25,27);1-10H,(H,25,28)(H2,24,26,27,29);1-8,10H,9H2,(H,24,27)(H2,23,25,26,28);1-11H,12H2,(H,22,25)(H2,21,23,24,26);1-10H,(H,22,25)(H2,21,23,24,26)
InChIKeyAJGPYEAPUGAECA-UHFFFAOYSA-N
MW1986.71 g/mol
LogP18.33
Rot. Bonds24

About 3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide

3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide (PubChem CID 157132771) has the molecular formula C100H74BrF5N20O16 and a molecular weight of 1986.71 g/mol. Its IUPAC name is 3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide.

Molecular Properties

Compound Name3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide
PubChem CID157132771
Molecular FormulaC100H74BrF5N20O16
Molecular Weight1986.71 g/mol
Exact Mass1984.47
IUPAC Name3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide
SMILESCOc1cccc(CC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)cc2)c1.O=C(Cc1cc(F)cc(F)c1)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)cc1.O=C(Cc1ccccc1)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)cc1.O=C(Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)cc1)c1cccc(Br)c1.O=C(Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)cc1)c1cccc(C(F)(F)F)c1
InChIInChI=1S/C21H18N4O4.C20H13F3N4O3.C20H14F2N4O3.C20H16N4O3.C19H13BrN4O3/c1-28-16-4-2-3-13(11-16)12-18(26)23-14-5-7-15(8-6-14)29-17-9-10-22-20-19(17)24-21(27)25-20;21-20(22,23)12-3-1-2-11(10-12)18(28)25-13-4-6-14(7-5-13)30-15-8-9-24-17-16(15)26-19(29)27-17;21-12-7-11(8-13(22)10-12)9-17(27)24-14-1-3-15(4-2-14)29-16-5-6-23-19-18(16)25-20(28)26-19;25-17(12-13-4-2-1-3-5-13)22-14-6-8-15(9-7-14)27-16-10-11-21-19-18(16)23-20(26)24-19;20-12-3-1-2-11(10-12)18(25)22-13-4-6-14(7-5-13)27-15-8-9-21-17-16(15)23-19(26)24-17/h2-11H,12H2,1H3,(H,23,26)(H2,22,24,25,27);1-10H,(H,25,28)(H2,24,26,27,29);1-8,10H,9H2,(H,24,27)(H2,23,25,26,28);1-11H,12H2,(H,22,25)(H2,21,23,24,26);1-10H,(H,22,25)(H2,21,23,24,26)
InChIKeyAJGPYEAPUGAECA-UHFFFAOYSA-N
XLogP18.33
TPSA508.58 Ų
H-Bond Donors15
H-Bond Acceptors21
Rotatable Bonds24
Heavy Atoms142
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001986.71
LogP ≤ 518.33
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1021

Analyze 3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(8Z)-13-bromo-11-oxa-3,6,19,24-tetrazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,8,12(17),13,15,20,22-nonaen-18-one;(8E)-13-bromo-11-oxa-3,6,19,24-tetrazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,8,12(17),13,15,20,22-nonaen-18-one;(8E)-14-bromo-11-oxa-3,6,19,24-tetrazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,8,12(17),13,15,20,22-nonaen-18-one;13-bromo-11-oxa-3,6,19,24-tetrazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(8Z)-13-methyl-11-oxa-3,6,19,24-tetrazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,8,12,14,16,20,22-nonaen-18-one;(8E)-15-morpholin-4-yl-11-oxa-3,6,19,24-tetrazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,8,12(17),13,15,20,22-nonaen-18-one;(8E)-13-(trifluoromethyl)-11-oxa-3,6,19,24-tetrazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,8,12(17),13,15,20,22-nonaen-18-one
CID 158876801
3-bromo-N-pentyl-N-[(3-propylimidazo[4,5-b]pyridin-2-yl)methyl]benzamide;2-fluoro-N-[(4-fluorophenyl)methyl]-N-[(3-propylimidazo[4,5-b]pyridin-2-yl)methyl]-6-(trifluoromethyl)benzamide;3-fluoro-N-methyl-N-[(3-propylimidazo[4,5-b]pyridin-2-yl)methyl]benzamide;3-fluoro-N-prop-2-enyl-N-[(3-propylimidazo[4,5-b]pyridin-2-yl)methyl]benzamide;3-[2-(3-methoxypropylamino)ethoxy]-N-(3-methylbutyl)-N-[(3-propylimidazo[4,5-b]pyridin-2-yl)methyl]benzamide
CID 160261052
3-bromo-N-(3-methylbutyl)-N-[(3-propylimidazo[4,5-b]pyridin-2-yl)methyl]benzamide;N-[(3-cyclopentylimidazo[4,5-b]pyridin-2-yl)methyl]-2,4,6-trifluoro-N-(2-methylpropyl)benzamide;3-fluoro-N-propyl-N-[(3-propylimidazo[4,5-b]pyridin-2-yl)methyl]benzamide;3-[2-(3-methoxypropylamino)ethoxy]-N-(2-methylpropyl)-N-[(3-propylimidazo[4,5-b]pyridin-2-yl)methyl]benzamide
CID 161141853

Frequently Asked Questions

What is the IUPAC name of 3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide?
The IUPAC name of 3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide (CID 157132771) is 3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide.
What is the SMILES notation for 3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide?
The canonical SMILES for 3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide is COc1cccc(CC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)cc2)c1.O=C(Cc1cc(F)cc(F)c1)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)cc1.O=C(Cc1ccccc1)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)cc1.O=C(Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)cc1)c1cccc(Br)c1.O=C(Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)cc1)c1cccc(C(F)(F)F)c1.
What is the InChIKey of 3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide?
The InChIKey is AJGPYEAPUGAECA-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H18N4O4.C20H13F3N4O3.C20H14F2N4O3.C20H16N4O3.C19H13BrN4O3/c1-28-16-4-2-3-13(11-16)12-18(26)23-14-5-7-15(8-6-14)29-17-9-10-22-20-19(17)24-21(27)25-20;21-20(22,23)12-3-1-2-11(10-12)18(28)25-13-4-6-14(7-5-13)30-15-8-9-24-17-16(15)26-19(29)27-17;21-12-7-11(8-13(22)10-12)9-17(27)24-14-1-3-15(4-2-14)29-16-5-6-23-19-18(16)25-20(28)26-19;25-17(12-13-4-2-1-3-5-13)22-14-6-8-15(9-7-14)27-16-10-11-21-19-18(16)23-20(26)24-19;20-12-3-1-2-11(10-12)18(25)22-13-4-6-14(7-5-13)27-15-8-9-21-17-16(15)23-19(26)24-17/h2-11H,12H2,1H3,(H,23,26)(H2,22,24,25,27);1-10H,(H,25,28)(H2,24,26,27,29);1-8,10H,9H2,(H,24,27)(H2,23,25,26,28);1-11H,12H2,(H,22,25)(H2,21,23,24,26);1-10H,(H,22,25)(H2,21,23,24,26).
What are the key properties of 3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide?
3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide has a molecular weight of 1986.71 g/mol, XLogP of 18.33, 24 rotatable bonds, 15 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromo-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide;2-(3,5-difluorophenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;2-(3-methoxyphenyl)-N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]acetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-2-phenylacetamide;N-[4-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-3-(trifluoromethyl)benzamide is sourced from PubChem (CID 157132771), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).